Correction: Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity

• April W. Armstrong,
• Tarannum Jaleel,
• Joseph F. Merola,
• Alice B. Gottlieb,
• Saakshi Khattri,
• Cameron C. Helt,
• William N. Malatestinic,
• Sarah E. Ross,
• Marcus E. Ngantcha,
• Kurt de Vlam

Affiliations

April W. Armstrong

University of California

Tarannum Jaleel

Department of Dermatology, Duke University School of Medicine

Joseph F. Merola

Department of Dermatology and Department of Medicine, Division of Rheumatology, UT Southwestern

Alice B. Gottlieb

Department of Dermatology, Icahn School of Medicine

Saakshi Khattri

Department of Dermatology, Icahn School of Medicine

Cameron C. Helt

Eli Lilly and Company, Lilly Corporate Center

William N. Malatestinic

Eli Lilly and Company, Lilly Corporate Center

Sarah E. Ross

Eli Lilly and Company, Lilly Corporate Center

Marcus E. Ngantcha

Eli Lilly and Company, Lilly Corporate Center

Kurt de Vlam

Department of Rheumatology, University Hospitals Leuven